Unicycive Therapeutics, Inc. (UNCY) stock
UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$3.57−0.13 (-3.51%)
Close on Nov 18, 2026Market cap $99.44MP/E –Yield –
Unicycive Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Unicycive Therapeutics's enterprise value was $43.87M on Nov 11, 2026, against $92.21M a year earlier. Over the last 5 years it ranged from -$32.49M to $131.67M, with a median of $19.35M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $43.87M | -43.5% |
| 2025 | Dec 31, 2025 | $77.61M | +71.1% |
| 2024 | Dec 31, 2024 | $45.37M | +187.0% |
| 2023 | Dec 29, 2023 | $15.81M | +1290.0% |
| 2022 | Dec 30, 2022 | $1.14M | -91.1% |
| 2021 | Dec 31, 2021 | $12.83M | – |
See a number that looks wrong?